Towards finding therapeutic molecules for ALS, efforts at identifying inhibitors of TDP-43 aggregation have involved examining small molecules like methylene blue and dimebon, however, results from clinical trials have not been very encouraging31. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.